FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/28/2023
Back to search
Official data from USPTO
CR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
08/28/2023
Trademark type
Combined
Nice classes
5, 42
Filing date
02/23/2022
Registration date
04/25/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/25/2023
Last transaction
04/25/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CN
Examiner
GARCIA, CLAUDIA
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of an abstract design consisting of circular and curved line shapes depicting the letters "CR".
Holders and representatives
Holders
Corregene Biotechnology Co., Ltd
Representatives
Nazly Aileen Bayramoglu BAYRAMOGLU LAW OFFICES LLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical reagents for medical or veterinary purposes; disinfectants; radioactive substances for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; nutritive substances for microorganisms cultures; diagnostic preparations for medical purposes; Biological preparations for medical purposes for the treatment of tumorscancerprecancerous lesionschronic infectionsautoimmune diseasesfatty liverinflammatory bowel diseasecervical neoplasiaviral infectionsmetabolic diseasesimmunodeficiencyosteoarthritisthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesallergicimmune disorderTORCH infections and immunoglobulin diseases; surgical implants comprised of living tissues; veterinary preparations for the prevention and treatment of intestinal bacteriacolibacillosissalmonellosispasteurellabrucellosisfoot-and-mouth diseasetuberculosisplagueinfectious diseasesinfluenzaimmune related diseases and nutrient deficiency related diseases; preparations for destroying noxious animals
Class 42
Product quality testing services; technological research in the field of medicines and biological preparations; research and development of pharmaceuticals for the treatment of tumorscancerprecancerous lesionschronic infectionsautoimmune diseasesfatty liverinflammatory bowel diseasecervical neoplasiaviral infectionsmetabolic diseasesimmunodeficiencyosteoarthritisthyroid diseaseglycometabolism diseasebone metabolic diseasegonad diseasekidney diseasecardiovascular diseasehepatic fibrosisanemiainflammation diseaseshepatitis diseaseEpstein-Barr (EB) viruseshormonal diseasesallergicimmune disorderTORCH infections and immunoglobulin diseases; genome structure and function analysis; genetic testing for scientific research purposes; Medical and scientific researchconducting clinical trials for others; The testing of starting materialsintermediate products and end products of proteincell and gene therapy pharmaceutical products
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/04/2023
FIMP
FINAL DISPOSITION PROCESSED
08/04/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/25/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/25/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/25/2023
GPNX
NOTIFICATION PROCESSED BY IB
02/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2023
PUBO
PUBLISHED FOR OPPOSITION
02/07/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/18/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/18/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/18/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/16/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/15/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/15/2022
RFNP
REFUSAL PROCESSED BY IB
11/15/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/22/2022
RFRR
REFUSAL PROCESSED BY MPU
10/21/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/31/2022
CNRT
NON-FINAL ACTION WRITTEN
08/30/2022
DOCK
ASSIGNED TO EXAMINER
08/25/2022
MAFR
APPLICATION FILING RECEIPT MAILED
05/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/29/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/28/2022
Continuous trademark protection
Get notified about every new filing that threatens CR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.